Funde Hong Kong Completes Acquisition of Guanze Medical Information Industry

Reuters
Feb 11
Funde Hong Kong Completes Acquisition of <a href="https://laohu8.com/S/02427">Guanze Medical</a> Information Industry

Funde (Hong Kong) Investment Holdings Co., Limited has completed the acquisition of shares in Guanze Medical Information Industry (Holding) Co., Ltd. Following this, Aristo Securities Limited, on behalf of Funde (Hong Kong) Investment Holdings Co., Limited, has made a cash offer to acquire all remaining issued shares of Guanze Medical Information Industry (Holding) Co., Ltd. not already owned or agreed to be acquired by Funde (Hong Kong) Investment Holdings Co., Limited, its ultimate beneficial owners, or parties acting in concert with them.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guanze Intelligent Medical Information Industry Holding Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260211-12022451), on February 11, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10